BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barnett V, Twycross R, Mihalyo M, Wilcock A. Opioid Antagonists. Journal of Pain and Symptom Management 2014;47:341-52. [DOI: 10.1016/j.jpainsymman.2013.12.223] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Zádor F, Király K, Váradi A, Balogh M, Fehér Á, Kocsis D, Erdei AI, Lackó E, Zádori ZS, Hosztafi S, Noszál B, Riba P, Benyhe S, Fürst S, Al-Khrasani M. New opioid receptor antagonist: Naltrexone-14-O-sulfate synthesis and pharmacology. Eur J Pharmacol 2017;809:111-21. [PMID: 28502630 DOI: 10.1016/j.ejphar.2017.05.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
2 Sharifi F, Meqbil YJ, Otte A, Gutridge AM, Blaine AT, van Rijn RM, Park K. Engineering Quick- and Long-acting Naloxone Delivery Systems for Treating Opioid Overdose. Pharm Res 2021;38:1221-34. [PMID: 34114163 DOI: 10.1007/s11095-021-03069-x] [Reference Citation Analysis]
3 Cox F. An overview of pain assessment and management. Nurs Stand 2022. [PMID: 35352514 DOI: 10.7748/ns.2022.e11936] [Reference Citation Analysis]
4 Juneja R. Opioids and cancer recurrence. Curr Opin Support Palliat Care. 2014;8:91-101. [PMID: 24759319 DOI: 10.1097/spc.0000000000000056] [Cited by in Crossref: 46] [Cited by in F6Publishing: 18] [Article Influence: 6.6] [Reference Citation Analysis]
5 Huang H, Liu B, Qu N, Zhang S, Bai X, Handley M, Shan F. Research progress of opioid growth factor in immune-related diseases and cancer diseases. Int Immunopharmacol 2021;99:107713. [PMID: 34426103 DOI: 10.1016/j.intimp.2021.107713] [Reference Citation Analysis]
6 Kantonen T, Karjalainen T, Pekkarinen L, Isojärvi J, Kalliokoski K, Kaasinen V, Hirvonen J, Nuutila P, Nummenmaa L. Cerebral μ-opioid and CB1 receptor systems have distinct roles in human feeding behavior. Transl Psychiatry 2021;11:442. [PMID: 34453034 DOI: 10.1038/s41398-021-01559-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
7 Bigliardi PL, Dancik Y, Neumann C, Bigliardi‐qi M. Opioids and skin homeostasis, regeneration and ageing – What's the evidence? Exp Dermatol 2016;25:586-91. [DOI: 10.1111/exd.13021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
8 Tarr B, Launay J, Benson C, Dunbar RIM. ‘Naltrexone Blocks Endorphins Released when Dancing in Synchrony’. Adaptive Human Behavior and Physiology 2017;3:241-54. [DOI: 10.1007/s40750-017-0067-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 3.6] [Reference Citation Analysis]
9 Beaulieu P. Anesthetic implications of recreational drug use. Can J Anaesth 2017;64:1236-64. [PMID: 28956316 DOI: 10.1007/s12630-017-0975-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
10 Imam MZ, Kuo A, Ghassabian S, Smith MT. Progress in understanding mechanisms of opioid-induced gastrointestinal adverse effects and respiratory depression. Neuropharmacology 2018;131:238-55. [PMID: 29273520 DOI: 10.1016/j.neuropharm.2017.12.032] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 9.4] [Reference Citation Analysis]
11 Crowe KM, Siddiqui Z, Harbour V, Kim K, Syed S, Paul R, Roy A, Naik R, Mitchell K, Mahajan A, Sarkar B, Kumar VA. Evaluation of Injectable Naloxone-Releasing Hydrogels. ACS Appl Bio Mater 2020;3:7858-64. [PMID: 35019526 DOI: 10.1021/acsabm.0c01016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]